Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$427M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 3 |
STJ
St Jude Medical
STJ
|
+$235M |
| 4 |
JPMorgan Chase
JPM
|
+$211M |
| 5 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Outfront Media
OUT
$5.58B
| $4.31M | ﹤0.01% |
164,786
+12,260
| +8% | +$320K |
|
1427
PUT
Chord Energy
CHRD
$7.49B
| $4.3M | ﹤0.01% |
301,800
+88,700
| +42% | +$1.25M |
|
1428
CALL
Blackstone
BX
$109B
| $4.29M | ﹤0.01% |
144,400
-398,900
| -73% | -$12M |
|
|
BPT
1429
PUT
DELISTED
BP Prudhoe Bay Royalty Trust
BPT
| $4.29M | ﹤0.01% |
213,300
+200,200
| +1,528% | +$4.99M |
|
1430
Liberty Global Class A
LBTYA
$3.64B
| $4.28M | ﹤0.01% |
119,424
+36,780
| +45% | +$1.3M |
|
1431
PUT
Eaton
ETN
$174B
| $4.26M | ﹤0.01% |
57,500
+2,300
| +4% | +$163K |
|
1432
CALL
Kohl's
KSS
$2.14B
| $4.26M | ﹤0.01% |
107,100
+47,900
| +81% | +$1.96M |
|
1433
PUT
Applied Materials
AMAT
$427B
| $4.26M | ﹤0.01% |
109,400
+28,500
| +35% | +$1.02M |
|
|
CAB
1434
DELISTED
Cabela's Inc
CAB
| $4.26M | ﹤0.01% |
80,111
-62,941
| -44% | -$3.23M |
|
|
TIF
1435
CALL
DELISTED
Tiffany & Co.
TIF
| $4.25M | ﹤0.01% |
44,600
-51,000
| -53% | -$4.35M |
|
1436
CALL
Invesco
IVZ
$13.9B
| $4.24M | ﹤0.01% |
138,500
+61,500
| +80% | +$1.92M |
|
1437
PUT
Fluor
FLR
$8.02B
| $4.24M | ﹤0.01% |
80,600
-162,200
| -67% | -$8.85M |
|
1438
CALL
Teck Resources
TECK
$32.6B
| $4.24M | ﹤0.01% |
193,400
-15,100
| -7% | -$338K |
|
|
GWPH
1439
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.23M | ﹤0.01% |
35,000
-98,717
| -74% | -$12.1M |
|
|
ANDX
1440
DELISTED
Andeavor Logistics LP
ANDX
| $4.22M | ﹤0.01% |
77,534
+13,267
| +21% | +$736K |
|
1441
PUT
W.W. Grainger
GWW
$60.6B
| $4.21M | ﹤0.01% |
18,100
+13,400
| +285% | +$3.3M |
|
1442
International Flavors & Fragrances
IFF
$21.6B
| $4.21M | ﹤0.01% |
31,771
-13,651
| -30% | -$1.68M |
|
1443
Jack Henry & Associates
JKHY
$11.1B
| $4.2M | ﹤0.01% |
45,129
+20,998
| +87% | +$1.94M |
|
1444
PUT
Weyerhaeuser
WY
$18.4B
| $4.2M | ﹤0.01% |
123,500
-75,500
| -38% | -$2.46M |
|
1445
PUT
Danaher
DHR
$142B
| $4.19M | ﹤0.01% |
55,272
-46,699
| -46% | -$3.48M |
|
1446
PUT
Aflac
AFL
$62.9B
| $4.19M | ﹤0.01% |
115,600
-26,200
| -18% | -$928K |
|
1447
Acadia Pharmaceuticals
ACAD
$4.98B
| $4.18M | ﹤0.01% |
121,590
-10,356
| -8% | -$366K |
|
1448
Carter's
CRI
$1.47B
| $4.18M | ﹤0.01% |
46,523
+10,770
| +30% | +$928K |
|
1449
CALL
EOG Resources
EOG
$71.3B
| $4.17M | ﹤0.01% |
42,800
-110,900
| -72% | -$11.1M |
|
1450
Robert Half
RHI
$4.39B
| $4.17M | ﹤0.01% |
85,392
+13,228
| +18% | +$639K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.86B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was TotalEnergies, cutting an estimated $427M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.